Key takeaway
In 893 postmenopausal women aged 50 or older from NHANES 2007-2018, a higher systemic immune-inflammation index (SII) was associated with lower femur and femoral neck bone mineral density and with greater odds of low bone density or osteoporosis. This cross-sectional link cannot show that inflammation causes bone loss, and the abstract does not give effect sizes.
Study design
Cross-sectional study
Reading basis
Published abstract
Reading focus
Association & confounding
The research question
Chronic inflammation is thought to speed up bone loss, and the systemic immune-inflammation index is a simple blood-count ratio that might help flag risk. The authors tested whether SII, and several related blood markers, relate to bone mineral density (BMD) and to osteopenia or osteoporosis in postmenopausal women.
Who and how
Cross-sectional analysis of postmenopausal women aged ≥50 years in the National Health and Nutrition Examination Survey (NHANES) 2007-2018. BMD was measured by dual-energy X-ray absorptiometry. SII was calculated from lymphocyte, neutrophil and platelet counts, and other markers were platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio (NLR), the product of platelet and neutrophil counts (PPN) and the individual counts. Multivariable weighted linear regression examined BMD, and weighted logistic regression examined low BMD or osteoporosis. A total of 893 women (weighted mean age 60.90 ± 0.26 years) were included.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Higher SII was negatively associated with total femur and femoral neck BMD, and women in a higher SII quarter had lower lumbar spine BMD than those in the lowest quarter.
- 2Higher SII was associated with an increased risk of low BMD and osteoporosis. NLR and PPN were also negatively associated with BMD and positively associated with osteoporosis risk.
- 3In subgroup analyses the associations between BMD and inflammatory markers were pronounced in women aged ≥65 years or with normal BMI (<25 kg/m2).
Limits & uncertainty
- 1Cross-sectional data cannot show whether inflammation precedes bone loss or the reverse, and a single blood count may be affected by acute illness or medications.
- 2Only 893 women were included, and the subgroup findings by age and BMI were exploratory.
- 3The authors acknowledge limitations and call for larger studies; the abstract gives no effect sizes or confidence intervals. This reading is based on the abstract only.
What to take from it
A high SII may be one more signal of higher bone-loss risk in postmenopausal women, but it is not a diagnostic test. Bone density is checked by DXA scans, so women with concerns should talk with a clinician about bone health and screening rather than reacting to a blood count.
Reading your own data
SII comes from blood counts (lymphocytes, neutrophils, platelets) in a standard lab test, not from a wearable. If you keep lab results, compare them across years from the same lab and focus on trends; bone health itself is measured with a scan.
How to read this evidence
Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
This study aimed to investigate the association between the systemic immune-inflammation index (SII) and bone mineral density (BMD) and to determine the association between the SII and the risk of osteopenia/osteoporosis among postmenopausal women aged ≥50 years.
Methods
Postmenopausal women aged ≥50 years from the National Health and Nutrition Examination Survey were included. BMD testing was performed using dual-energy X-ray absorptiometry. The SII was calculated based on lymphocyte (LC), neutrophil (NC), and platelet (PC) counts. Moreover, the associations of BMD with SII and other inflammatory markers, including platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), the product of platelet count and neutrophil count (PPN), PC, NC, and LC, were assessed using a multivariable weighted linear regression model. Additionally, the associations of low BMD/osteoporosis with SII and other inflammatory markers were assessed using multivariable weighted logistic regression.
Results
Finally, a total of 893 postmenopausal women with a weighted mean age of 60.90 ± 0.26 years were included finally. This study found that SII was negatively associated with total femur BMD and femoral neck BMD, and postmenopausal women in a higher SII quarter group showed low lumbar spine BMD than the lowest SII quarter group when SII was converted from a continuous variable to a categorical variable. Moreover, increased SII was associated with an increased risk of low BMD and osteoporosis. In addition, this study observed that other inflammatory markers, especially NLR and PPN, were negatively associated with BMD and positively associated with the risk of osteoporosis. Finally, the subgroup analysis showed that the associations between BMD and inflammatory markers were pronounced in postmenopausal women aged ≥65 years or those with normal BMI (<25 kg/m^(2)).
Conclusion
SII may be a valuable and convenient inflammatory marker that could be applied to predict the risk of low BMD or osteoporosis among postmenopausal women aged ≥50. Moreover, postmenopausal women with a high level of SII or other inflammatory markers, such as NLR and PPN, should be aware of the potential risk of osteoporosis. However, given the inherent limitations of the present study, additional large-scale studies are required to investigate the role of SII in osteoporosis further.
Sources & attribution
Systemic immune-inflammation index and bone mineral density in postmenopausal women: A cross-sectional study of the national health and nutrition examination survey (NHANES) 2007-2018.
Tang Y, Peng B, Liu J, Liu Z, Xia Y, Geng B.
Frontiers in immunology · 2022-09-08
DOI: 10.3389/fimmu.2022.975400 ↗PubMed · 36159805 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

